Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Endonovo Therapeutics, Inc. (ENDV) had Operating Cash Flow per Share of $0.00 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$0.14M |
|
$6.92M |
|
$0.01M |
|
$0.13M |
|
$3.06M |
|
$-2.92M |
|
$9.84M |
|
$6.92M |
|
$6.92M |
|
$6.92M |
|
$6.92M |
|
$6.92M |
|
$6.92M |
|
$-2.92M |
|
$-2.23M |
|
276.36M |
|
1.35B |
|
$0.03 |
|
$0.01 |
|
| Balance Sheet Financials | |
$0.02M |
|
-- |
|
$0.62M |
|
$0.64M |
|
$24.67M |
|
-- |
|
$0.08M |
|
$24.75M |
|
$-24.11M |
|
$-24.73M |
|
$-24.11M |
|
318.75M |
|
| Cash Flow Statement Financials | |
$0.12M |
|
-- |
|
$-0.12M |
|
$0.00M |
|
$0.00M |
|
$0.00M |
|
$0.69M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.00 |
|
-- |
|
-- |
|
-- |
|
-0.29 |
|
94.41% |
|
-2081.72% |
|
-2081.72% |
|
-1591.47% |
|
4937.60% |
|
4937.60% |
|
$0.12M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
-- |
|
-- |
|
-- |
|
-28.72% |
|
-28.00% |
|
1085.21% |
|
-28.72% |
|
$-0.08 |
|
$0.00 |
|
|
Operating Cash Flow per Share |
$0.00 |